Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) surged 46.9% to $6.25 after the company announced the full details of its Phase 2 trial evaluating its lead drug candidate, RP5063 (brilaroxazine), for Acute Schizophrenia. Brilaroxazine demonstrated high affinity and selectivity for key serotonin receptors (5-HT1A/2A/2B/7) through its combination of potent affinity and selectivity for target receptors implicated for schizophrenia and its comorbid symptoms. Proofpoint, Inc. (NASDAQ:PFPT) shares climbed 31.5% to $173.22. Private equity investment firm Thoma Bravo Advantage inked an agreement to acquire cybersecurity and compliance company Proofpoint in an all-cash transaction valuing Proofpoint at $12.3 billion. MicroVision, Inc. (NASDAQ:MVIS) jumped 30% to $23.35 on continued momentum from Friday after investors showed interest in the stock on the r/wallstreetbets group on Reddit. Microvision closed over 36% higher on Friday. Casper Sleep Inc. (NYSE:CSPR) shares gained 25.2% to $8.81 after Wedbush upgraded the stock from Neutral to Outperform and raised its price target from $10 to $10.50per share. Jiayin Group Inc. (NASDAQ:JFIN) surged 24.7% to $7.16. Ocugen, Inc. (NASDAQ:OCGN) shares rose 23.3% to $11.88. Ocugen’s COVID-19 vaccine partner, India-based Bharat Biotech International Ltd., will charge as much as double its main rival AstraZeneca for its vaccines in India. Aeterna Zentaris Inc. (NASDAQ:AEZS) rose 18.1% to $1.1050. Intrusion Inc. (NASDAQ:INTZ) surged 15.1% to $17.87. Puxin Limited (NYSE:NEW) gained 15% to $4.3806. Intellicheck, Inc. (NYSE:IDN) shares rose 14.8% to $9.70. Treace Medical Concepts, Inc. (NASDAQ:TMCI) gained 13.7% to $29.03. Treace Medical Concepts shares gained 50% on Friday after the company priced its IPO at $17 per share. PHX Minerals Inc. (NYSE:PHX) rose 13.5% to $2.5999. Voyager Therapeutics, Inc. (NASDAQ:VYGR) surged 13.4% to $5.30 after the company announced it received FDA clearance of IND application for its gene therapy candidate VY-HTT01 for the treatment of Huntington’s disease. Luminar Technologies, Inc. (NASDAQ:LAZR) surged 13.3% to $25.13 after the company announced a partnership deal with Airbus to test autonomous flight technology. ZK International Group Co., Ltd. (NASDAQ:ZKIN) shares rose 13.2% to $6.70 after surging around 10% on Friday. Axsome Therapeutics, Inc. (NASDAQ:AXSM) jumped 13.1% to $59.81 after the company announced FDA acceptance and priority review


Comments are closed.